Glatiramer acetate for multiple sclerosis-Reference-Cited by-同舟云学术

Glatiramer acetate for multiple sclerosis

Published:2010-05-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

La Mantia Loredana¹,Munari Luca M²,Lovati Roberta³

Affiliation:

1. Fondazione I.R.C.C.S. - Istituto Neurologico C. Besta; Department of Neuroscience; Via Celoria, 11 Milano Italy 20133

2. Sapio Life; Via Silvio Pellico 48 Monza Italy 20052

3. Ospedale San Paolo; U.O. Oncologia; Di Rudini, 8 Milano Italy 20142

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004678.pub2/fullpdf

Reference161 articles.

1. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis;Bornstein;New England Journal of Medicine,1987

2. A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis;Bornstein;Neurology,1991

3. The effect of glatiramer acetate (Copaxone) on disease activity as measured by cerebral MRI in patients with relapsing-remitting multiple sclerosis (RRMS): a multi-center, randomized, double-blind, placebo-controlled study extended by open-label treatment;Comi;Neurology,1999

4. The extension phase of the European-Canadian MRI study demonstrates a sustained effect of glatiramer acetate in relapsing-remitting multiple sclerosis;Comi;Journal of Neurosurgery,2001

5. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of Glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing-remitting multiple sclerosis;Comi;Annals of Neurology,2001

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Nano-Engineered Stem Cells in the Treatment of Multiple Sclerosis: A Comprehensive Review;Cellular and Molecular Neurobiology;2023-12-17

2. Extracellular Matrix Protein 1 Attenuates Hepatic Fibrosis by Inhibiting TSP-, ADAMTS-, and MMP-Mediated Latent TGF-β1 Activation;2023-12-12

3. Methyl-CpG-Binding Protein 2 Emerges as a Central Player in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders;Cellular and Molecular Neurobiology;2023-11

4. Disease modifying therapy and pregnancy outcomes in multiple sclerosis: A systematic review and meta-analysis;Journal of Neuroimmunology;2023-10

5. A Grave Set of Diagnoses: A Case of Mania with Comorbid Autoimmune Thyroiditis Precipitated by Multiple Sclerosis Treatment;Harvard Review of Psychiatry;2023-08-22